SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

The biotech sector, tracked by LABU's underlying index XBI, is rallying strongly, driven by recent M&A activity like the Biomarin buyout and persistent optimism for AI's transformative role in drug discovery. While some caution about stretched technicals, the community is keenly discussing a potential sustained "catch-up rally" for biotech, further buoyed by anticipated rate cuts benefiting growth sectors.

SSgA Active Trust - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The Financial Select Sector SPDR Fund (XLF) is trending due to widespread technical weakness and a prevailing bearish sentiment, with community discussion highlighting a potential major breakdown and eyeing key support levels. Concerns over broader economic health, including consumer delinquencies, and policy discussions like potential credit card rate caps, are contributing to a cautious outlook despite mixed bank earnings reports.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending amid significant community frustration as the biotech sector's sustained rally defies bearish expectations, with many speculating on market manipulation and technical divergences while others anticipate an imminent reversal for the XBI.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is trending as cybersecurity stocks respond to the emergence of new AI code security tools, fueling community debate over potential disruption versus the significant new growth opportunity for Okta in securing AI agents and digital identities.

American Superconductor Corp. engages in the provision of megawatt-scale power solutions. Its products include electric control systems, generators & drivetrains, power converters, renewable interconnectivity solutions, software, turbine designs, utility and industrial resilience and modernization solutions, and utility voltage solutions. It operates through the Grid and Wind segments. The Grid segment enables electric utilities and renewable energy project developers to connect, transmit, and distribute power with efficiency, reliability, security, and affordability. The Wind segment permits the manufacturers to field wind turbines with power output, reliability, and affordability. The company was founded by Yet Ming Chiang, David A. Rudman, John B. Vander Sande, and Gregory J. Yurek on April 9, 1987 and is headquartered in Ayer, MA.

American Superconductor Corp.

American Superconductor is seeing heightened interest following a robust earnings report and optimistic guidance, driving community focus on its essential contributions to modernizing power grids for AI data centers and growing defense sector engagements.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is seeing heightened community discussion around its new Indensity battery storage system, a potential game-changer for AI data center power needs and grid modernization, as investors weigh its unique U.S.-made technology against lingering execution concerns ahead of an imminent earnings report.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP CRYPTO) is trending amid strong community belief in institutional accumulation and impending V4 partnerships, with discussions highlighting its limited supply and oversold status as key drivers for a potential breakout in the DeFi sector.

Forum Energy Technologies, Inc. designs, manufactures, and distributes products to the oil and natural gas industry. It operates through the Drilling and Completions and Artificial Lift and Downhole segments. The Drilling and Completions segment designs, manufactures and supplies products and solutions to the drilling, subsea, coiled tubing, well stimulation and intervention markets, including applications in oil and natural gas, renewable energy, defense and communications. The Artificial Lift and Downhole segment designs, manufactures and supplies products and solutions for the artificial lift, production and infrastructure markets. The company was founded in 2005 and is headquartered in Houston, TX.

Forum Energy Technologies Inc

Forum Energy Technologies (FET) is trending as recent financial results and an ambitious "FET 2030" plan reinforce strong long-term growth and value creation potential. The community is actively discussing the company's solid execution, robust free cash flow, and strategic debt reduction and buybacks, seeing it as significantly undervalued at the bottom of the cyclical oilfield services market.

Berachain

Berachain (BERA) is actively discussed for its innovative Proof-of-Liquidity (PoL) model, rapid growth in Total Value Locked (TVL), and recent ecosystem upgrades. This L1 crypto is experiencing significant price volatility, fueling a polarized community debate between proponents highlighting its technological potential and critics pointing to recent dips and token distribution concerns.

Icahn Enterprises LP operates as holding company. It operates through following eight business segments: Investment, Automotive, Energy, Food Packaging, Metals, Real Estate, Home Fashion, and Pharma. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group LLC. The Energy segment holds ownership in CVR Energy, Inc., which owns majority interests in two separate operating subsidiaries, CVR Refining, LP and CVR Partners, LP. The Food Packaging segment holds ownership in Viskase Cos., Inc., which is engaged in the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Metals segment operates through PSC Metals, Inc., which engages in the business of collecting, processing, and selling ferrous and non-ferrous metals, as well as the processing and distribution of steel pipe and plate products in the Midwest and Southern U.S. The Real Estate segment consists of rental real estate, property development and resort activities. The Home Fashion segment operates through WestPoint Home LLC, which consists of manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operates through Vivus, Inc., a specialized pharmaceutical company. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

Icahn Enterprises is trending as investors debate the sustainability of its significant dividend and the potential for a short squeeze amidst high short interest. Community focus is on the recent performance of its major CVR Energy holding, including reports of positive developments and EPA waivers that could lead to a dividend reinstatement, potentially boosting IEP's value despite ongoing concerns about dilution and its long-term share price trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSA Capital Partners LLP Increases Holdings in Taysha Gene Therapies, Inc. $TSHA

GSA Capital Partners LLP raised its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 969.0% during the third quarter, according to the company in its most recent Form 13F filing...

Taysha Gene Therapies (TSHA) Projected to Post Quarterly Earnings on Wednesday

Taysha Gene Therapies (NASDAQ:TSHA) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...

Commit To Buy Taysha Gene Therapies At $2.50, Earn 16.8% Annualized Using Options

Investors eyeing a purchase of Taysha Gene Therapies Inc (Symbol: TSHA) shares, but tentative about paying the going market price of $4.61/share, might benefit from considering selling puts among the...

Taysha Gene Therapies, Inc. $TSHA Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC cut its holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 93.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund...

Taysha Gene Therapies (NASDAQ:TSHA) Trading Down 6.2% - What's Next?

Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 6.2% - Here's What Happened...

Sukumar Nagendran Sells 200,000 Shares of Taysha Gene Therapies (NASDAQ:TSHA) Stock

Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the firm's stock in a transaction that occurred on Monday, January 12th. The stock was...

Insider Selling: Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells 200,000 Shares of Stock

Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the company's stock in a transaction that occurred on Monday, January 12th. The stock was...

Taysha Gene Therapies (NASDAQ:TSHA) Trading Down 6.3% - Should You Sell?

Taysha Gene Therapies (NASDAQ:TSHA) Shares Down 6.3% - Time to Sell...

Taysha Gene Therapies (NASDAQ:TSHA) Earns Buy Rating from Chardan Capital

Chardan Capital reissued a "buy" rating and issued a $12.00 target price on shares of Taysha Gene Therapies in a research report on Tuesday...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Recommendation of "Moderate Buy" from Analysts

Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) has earned a consensus rating of "Moderate Buy" from the thirteen brokerages that are covering the company, MarketBeat.com reports. One...

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and R. A. Session II in 2019 and is headquartered in Dallas, TX.

Current Price	$4.70
Prev Close	$4.79
Open	$4.75
Dividend Yield	0.00%
50-Day Moving Average	$5.05
Beta	1.64
Avg. Volume	2.8M
PE Ratio	-13.26

52-Week High	$6.02
52-Week Low	$1.05
Market Capitalization	$1.29B
EPS (Annual)	-$0.357
Price to Book	5.88
Revenue Per Employee	$114,150.68

TSHA
Taysha Gene Therapies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TSHA News

TSHATaysha Gene Therapies Inc